两款肿瘤药涉嫌逃税!阿斯利康称将面临最高450万美元罚款

第一财经
06 Feb

2月6日,阿斯利康表示,该公司已收到中国关于进口两款肿瘤药物未缴税款的通知,未缴税金额为90万美元。如果公司被判逃税,可能会被处以至多450万美元的罚款。阿斯利康中国前高管王磊自2024年10月底以来一直在接受调查,公司称仍在评估对关键市场部分高管调查的影响。当天,阿斯利康发布了第四季度财报。公司表示,因涉嫌未缴纳价值90万美元药品的进口税而受到调查,这可能导致公司最终被判缴纳该金额的1至5倍罚款...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10